4processed
Form 4 — Insider Transaction
LIGAND PHARMACEUTICALS INC(LGNYZ)
Filing Date
June 1, 2026
Accepted
June 1, 2026
Accession No.
0002001011-26-000083
CIK
0000886163
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Reardon Andrew | CLO & Secretary | Other | 5.0K | $52.27 | — | 46.4K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 491 | $223.947 | — | 45.9K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 677 | $225.198 | — | 45.2K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 1.4K | $225.967 | — | 43.8K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 400 | $226.779 | — | 43.4K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 584 | $228.574 | — | 42.8K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 1.2K | $229.468 | — | 41.6K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 200 | $230.41 | — | 41.4K | Common Stock | Jun 1, 2026 |
| Reardon Andrew | CLO & Secretary | Other | 5.0K | $0 | — | 39.4K | Employee Stock Option (right to buy) | Jun 1, 2026 |